Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesMolecular ImagingHow AI can help with PET/CT guideline deviationsResearchers have found a gap between what international PET/CT guidelines recommend and what actually happens in clinical practice.MRIMRI reveals how hidden muscle fat increases risk to heart, metabolismMolecular ImagingThe EANM joins EMUC26 and pushes its policy agenda in BrusselsMRIWhole body MRI, deep-learning can 'map' distribution of fat and muscleSponsor ContentTurning Innovation into Everyday Efficiency